Alimera Sciences Inc. (ALIM)
NASDAQ: ALIM
· Real-Time Price · USD
5.54
-0.01 (-0.18%)
At close: Sep 13, 2024, 10:00 PM
Alimera Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -14.7M | -21.41M | -20.13M | -20.13M | -24.03M | -17.12M | -18.11M | -18.43M | -17.36M | -6.68M | -4.37M | -1.24M | 2.32M | -7.79M |
Depreciation & Amortization | 12.38M | 11.15M | 8.75M | 6.39M | 3.89M | 2.7M | 2.71M | 2.68M | 2.67M | 2.63M | 2.58M | 2.58M | 2.61M | 2.66M |
Stock-Based Compensation | 3.29M | 2.05M | 1.44M | 817K | 771K | 824K | 910K | 962K | 1.06M | 1.05M | 997K | 1.01M | 1.09M | 1.15M |
Other Working Capital | 3.54M | 2.59M | 1.92M | 723K | -162K | 179K | 1.07M | -14K | 155K | -672K | -609K | -1.16M | -1.29M | -1.45M |
Other Non-Cash Items | 18.7M | 8.99M | 3.27M | 1.09M | 1.29M | 1.11M | 1.54M | 1.47M | 2.05M | 1.29M | 816K | 616K | -181K | 794K |
Deferred Income Tax | 1.16M | 8.22M | 8.22M | 8.3M | 7.39M | 285K | 285K | 779K | 779K | -1.77M | -1.9M | -2.47M | -2.91M | -470K |
Change in Working Capital | -11.56M | -16.28M | -15.8M | -14.75M | 321K | 6.23M | 2.69M | -1.87M | -4.42M | -3.46M | -1.35M | 702K | -1.15M | -1.59M |
Operating Cash Flow | -5.6M | -12.62M | -14.26M | -18.28M | -10.37M | -5.97M | -9.97M | -14.41M | -15.23M | -6.94M | -3.22M | 1.2M | 1.78M | -5.24M |
Capital Expenditures | -221K | -75.54M | -75.53M | -75.53M | -75.66M | -115K | -255K | -292K | -472K | -686K | -621K | -585K | -593K | -679K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -75.27M | -150.54M | -150.54M | -75.27M | -75.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -221K | -75.54M | -75.53M | -75.53M | -75.66M | -115K | -255K | -292K | -472K | -686K | -621K | -585K | -593K | -679K |
Debt Repayment | 4.58M | 24.51M | 22.02M | 21.99M | 22.16M | 2.15M | -289K | -225K | -313K | -226K | -221K | -264K | -326K | 1.36M |
Common Stock Repurchased | 938K | 938K | 624K | -314K | -314K | -314K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -1.26M | -1.26M | -1.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -6.87M | -4.06M | -5.29M | -5.42M | -4.71M | -3.22M | -98K | 15K | -1K | 10M | 10M | 10.02M | 10.03M | 23K |
Financial Cash Flow | -1.97M | 89.47M | 96.5M | 96.38M | 96.98M | 9.76M | -302K | -128K | -232K | 9.82M | 9.82M | 9.8M | 9.73M | 1.41M |
Net Cash Flow | -7.95M | 1.23M | 6.79M | 2.77M | 10.92M | 3.14M | -11.24M | -16.02M | -16.93M | 1.68M | 5.3M | 10.27M | 11.29M | -3.97M |
Free Cash Flow | -5.82M | -88.16M | -89.79M | -93.81M | -86.03M | -6.09M | -10.23M | -14.7M | -15.7M | -7.62M | -3.85M | 611K | 1.19M | -5.92M |